EUVIMEDEUVIMED entdecken
Crossref

Senescence Reprogramming Unleashes Tumor Immune Surveillance via Coordinated Gene Modulation

Kai Zhao, Yu Yan, Bao-Ting Dong, Shan-Shan Pan, Xian-Zheng Zhang iD

Advanced Materials · 2026

DOI: 10.1002/adma.202516597 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2026. Verfasst von Kai Zhao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Department of Traditional Chinese Medicine of Zhongnan Hospital, Key Laboratory of Biomedical Polymers of Ministry of Educat…. Hauptthemen laut MEDLINE: Cellular Senescence, Immunologic Surveillance, Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cellular senescence can recruit immune cells for tumor therapy through the senescence‐associated secretory phenotype (SASP). However, its therapeutic efficacy is limited by immune tolerance and the immunosuppressive tumor microenvironment (TME). Reprogramming tumor‐specific senescence through coordinated modulation of P16 INK4a and PD‐L1 enhances tumor immunogenicity and alleviates immunosuppression. To achieve this, a target‐enhanced gene delivery nanoparticle is engineered using the urokinase plasminogen activator receptor (uPAR) as a senescence‐specific targeting ligand, combined with a telomerase reverse transcriptase (TERT) promoter and a nuclear localization signal‐microtubule‐associated sequence (NLS‐MTAS) peptide. This system efficiently induces tumor‐specific senescence through cell‐cycle arrest and promotes the chemotactic recruitment of cytotoxic immune cells. In vivo, the nanoparticle induces a robust anti‐tumor response without causing systemic toxicity and significantly enhances the therapeutic efficacy of αCTLA‐4 immune checkpoint blockade in subcutaneous, lung metastasis, postoperative recurrence, and spontaneous tumor models. This study emphasizes the therapeutic potential of reprogramming tumor‐specific senescence to improve targeted gene delivery and immunotherapy outcomes, offering a viable approach for the treatment of immunologically “cold” tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cellular SenescenceImmunologic SurveillanceNeoplasmsAnimalsHumansMiceTelomeraseCell Line, TumorNanoparticlesTumor MicroenvironmentB7-H1 AntigenReceptors, Urokinase Plasminogen ActivatorCyclin-Dependent Kinase Inhibitor p16

Stichwörter der Autor:innen

PD‐L1 expressioncancer treatmentcellular senescencegene deliveryimmunotherapy

Substanzen

TelomeraseB7-H1 AntigenReceptors, Urokinase Plasminogen ActivatorCyclin-Dependent Kinase Inhibitor p16

Autor:innen und Institutionen

  • Department of Chemistry, Department of Traditional Chinese Medicine of Zhongnan Hospital, Key Laboratory of Biomedical Polymers of Ministry of Education, Wuhan University, Wuhan, 430072, P.R. China.

ORCID-Profile: Xian-Zheng Zhang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhao, K., Yan, Y., Dong, B. T., Pan, S. S., & Zhang, X. Z. (2026). Senescence Reprogramming Unleashes Tumor Immune Surveillance via Coordinated Gene Modulation. Advanced Materials. https://doi.org/10.1002/adma.202516597

Vancouver

Zhao K, Yan Y, Dong BT, Pan SS, Zhang XZ. Senescence Reprogramming Unleashes Tumor Immune Surveillance via Coordinated Gene Modulation. Advanced Materials. 2026. doi:10.1002/adma.202516597

BibTeX
@article{Zhao2026,
  author = {Zhao, Kai and Yan, Yu and Dong, Bao-Ting and Pan, Shan-Shan and Zhang, Xian-Zheng},
  title = {Senescence Reprogramming Unleashes Tumor Immune Surveillance via Coordinated Gene Modulation},
  journal = {Advanced Materials},
  year = {2026},
  doi = {10.1002/adma.202516597}
}
Kostenlos starten →